Gene: MLX
Official Full Name: MAX dimerization protein MLXprovided by HGNC
Gene Summary: The product of this gene belongs to the family of basic helix-loop-helix leucine zipper (bHLH-Zip) transcription factors. These factors form heterodimers with Mad proteins and play a role in proliferation, determination and differentiation. This gene product may act to diversify Mad family function by its restricted association with a subset of the Mad family of transcriptional repressors, namely, Mad1 and Mad4. Alternatively spliced transcript variants encoding different isoforms have been identified for this gene. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO35079 | MLX Knockout cell line (HeLa) | Human | MLX | 1:3~1:6 | Negative | Online Inquiry |
KO35080 | MLX Knockout cell line (HCT 116) | Human | MLX | 1:2~1:4 | Negative | Online Inquiry |
KO35081 | MLX Knockout cell line (HEK293) | Human | MLX | 1:3~1:6 | Negative | Online Inquiry |
MLX Gene Knockout Cell Lines represent a cutting-edge tool in molecular biology and genetic research, designed to facilitate the study of gene function through precise, targeted deletions of the MLX gene. These cell lines utilize the CRISPR/Cas9 gene editing technology, which allows for highly effective and specific genomic modifications. By knocking out the MLX gene, researchers can investigate its roles in various biological pathways, including metabolism, cellular signaling, and development, thus unveiling the underlying mechanisms of physiological and pathological processes.
The key functions of MLX Gene Knockout Cell Lines lie in their ability to replicate the effects of gene loss in endogenous systems, providing insights into gene interactions and cellular responses. Researchers can conduct assays to assess changes in cell proliferation, differentiation, and metabolic activity, all critical for understanding the ramifications of MLX gene function in disease states, such as cancer and metabolic disorders.
The scientific importance of these cell lines extends into numerous applications within both research and clinical settings. They serve as invaluable models for testing therapeutic interventions, screening drug candidates, and elucidating the molecular pathways relevant to MLX-associated conditions. Furthermore, the reproducibility of results obtained from these knockout models enhances their reliability, making them widely regarded among the research community.
One of the primary advantages of MLX Gene Knockout Cell Lines is their ease of use and customization. Unlike traditional knockout techniques, which can be time-consuming and less precise, this product delivers a streamlined approach to gene editing with minimal off-target effects. This precision is pivotal for obtaining cleaner data, ultimately leading to more dependable conclusions.
In addition to their robust functionality, these cell lines are backed by comprehensive technical support and validation data provided by our company, a leader in biological research tools. Our expertise in gene editing technologies and commitment to quality ensure that MLX Gene Knockout Cell Lines will significantly enhance your research capabilities and outcomes, providing the tools necessary to advance scientific knowledge in the field.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.